Melvin Keith Castle v. HHS - Tdap, neuropathy, thrombocytopenia, lymphadenopathy, central vestibular system impairment (2017)

Melvin Keith Castle filed a petition on March 4, 2015, under the National Vaccine Injury Compensation Program, alleging that a Tdap vaccine administered on January 24, 2014, caused him to suffer neuropathy, thrombocytopenia, lymphadenopathy, and central vestibular system impairment. The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr.

Castle's alleged injuries or his current condition. Despite this denial, on December 1, 2016, both parties filed a joint stipulation agreeing to an award of compensation.

Special Master Thomas L. Gowen reviewed the stipulation, found it reasonable, and adopted it as the decision of the Court.

The stipulation provided for a lump sum payment of $20,000.00, payable to Mr. Castle, as compensation for all damages.

Judgment was entered in accordance with the terms of the stipulation. Petitioner was represented by William E.

Cochran of Black MacLaren, et al., PC, and respondent was represented by Lara A. Englund of the United States Department of Justice.

The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses.